Wells Fargo & Company BIOMARIN PHARMACEUTICAL INC Transaction History

Wells Fargo & Company

  • $468 Billion
  • Q2 2025
Number of Shares
1,597,000
Previous 1,623,000 1.6%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
SELL
N/A
-26,000 Reduced 1.6%
1,597,000 $0
Q1 2025

May 13, 2025
SELL
N/A
-1,043,000 Reduced 39.12%
1,623,000 $0
Q4 2024

Feb 12, 2025
SELL
N/A
-83,000 Reduced 3.02%
2,666,000 $0
Q3 2024

Nov 13, 2024
SELL
N/A
-114,000 Reduced 3.98%
2,749,000 $0
Q2 2024

Aug 13, 2024
BUY
N/A
2,737,000 Added 2172.22%
2,863,000 $0
Q4 2023

Feb 09, 2024
BUY
N/A
125,000 Added 12500.0%
126,000 $0
Q2 2023

Aug 15, 2023
BUY
N/A
1,000 New
1,000 $0
Q1 2022

May 16, 2022
SELL
N/A
-299,000 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
N/A
299,000 New
299,000 $309,000
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email